Regulatory safety evaluation of nanomedical products: key issues to refine.

De Jong, Wim H; Geertsma, Robert E; Borchard, Gerrit

De Jong, Wim H; Geertsma, Robert E; Borchard, Gerrit.

Afiliação

De Jong WH; Formerly (retired) National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Geertsma RE; National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Borchard G; University of Geneva, Geneva, Switzerland. Gerrit.Borchard@unige.ch.

Drug Deliv Transl Res ; 12(9): 2042-2047, 2022 09.

Article em En | MEDLINE | ID: mdl-35908133

Assuntos

Nanomedicina; Nanoestruturas; Nanomedicina/métodos; Nanoestruturas/efeitos adversos; Nanotecnologia

Palavras-chave

Immune system; Nanomedicines; Regulations; Safety evaluation

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Nanoestruturas / Nanomedicina Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google